A -day-old female infant arrives at the emergency department presenting with worsening lethargy, recurrent vomiting, and poor feeding over the past hours. She has been exclusively breastfed since birth. Physical examination demonstrates marked scleral icterus, hypotonia, and a liver edge palpable cm below the right costal margin. Initial point-of-care blood glucose is mg/dL. A urinalysis is negative for glucose but strongly positive for reducing substances. Arrange the following management and diagnostic steps in the most appropriate sequential order for this patient.
- 1Administer an intravenous dextrose bolus to correct the acute hypoglycemia.
- 2Discontinue breast milk to halt the intake of dietary lactose.
- 3Obtain blood cultures and initiate empiric antibiotics for suspected Escherichia coli sepsis.
- 4Confirm the diagnosis by measuring erythrocyte galactose-1-phosphate uridyltransferase (GALT) activity.
- 5Consult ophthalmology for a slit-lamp examination to evaluate for oil-drop cataracts.
Answer
The correct sequence is to first administer intravenous dextrose, then discontinue breast milk, initiate a sepsis evaluation with empiric antibiotics, confirm the diagnosis with a GALT activity assay, and finally schedule an ophthalmologic screening for cataracts.
The correct sequence fundamentally prioritizes immediate physiological resuscitation (correcting hypoglycemia), followed closely by the elimination of the specific toxic trigger (stopping lactose). Once the immediate primary crisis is arrested, clinicians must address the highest-risk acute complication (E. coli sepsis). Only after the patient is fully stabilized and protected from acute threats should definitive diagnostic testing (enzymatic assay) and subacute complication screening (cataracts) be pursued.
Step-by-Step Solution
Key Concept
In acute neonatal metabolic crises such as classic galactosemia, management must strictly follow the sequence of physiologic resuscitation (treating hypoglycemia), elimination of the dietary toxin (stopping lactose), treatment of acute complications (E. coli sepsis), definitive diagnosis (GALT assay), and long-term complication screening (cataracts).